Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity

Clinical Microbiology and Infection

Volumn 20, Issue 4, 2014, Pages

  Sutherland, J S ^a   Loxton, A G ^b   Haks, M C ^c   Kassa, D ^d   Ambrose, L ^e   Lee, J S ^f   Ran, L ^g   van Baarle, D ^g   Maertzdorf, J ^h   Howe, R ⁱ   Mayanja Kizza, H ^j   Boom, W H ^k   Thiel, B A ^k   Crampin, A C ^e   Hanekom, W ^l,l   Ota, M O C ^a   Dockrell, H ^f   Walzl, G ^b   Kaufmann, S H E ^h   Ottenhoff, T H M ^c   Beyers, N ^b   van Helden, P ^b   Thompson, B ^b   Loxton, A ^b   Chegou, N ^b   Black, G ^b   Kriel, D ^b   Stanley, K ^b   Golakai, H ^b   Du Plessis, N ^b   van der Spuy, G ^b   Ota, M ^m   Sutherland, J ^m   Adetifa, I ^m   Togun, T ^m   Donkor, S ^m   Antonio, M ^m   Hill, P ^m   Adegbola, R ^m   Henry Boom, W ^k   Chervenak, K ^k   Thiel, B ^k   Heaphy, E ^k   Joloba, M ^j   Zalwango, S ^j   Nsereko, M ^j   Okwera Hussein Kisingo, B ^j   Baseke, J ^j   Buteme, H ^j   Nalukwango, S ^j   Crampin, M ^e   French, N ^e   Ngwira, B ^e   Ben Smith, A ^e   Watkins, K ^e   Simukonda, F ^e   Mvula, H ^e   Chilongo, F ^e   Saul, J ^e   Branson, K ^e   Lalor, M ^f   Smith, S ^f   Gorak Stolinska, P ^f   Hur, Y G ^f   Blitz, R ^f   Ottenhoff, T ^c   Haks, M ^c   Franken, K ^c   Joosten, S ^c   Friggen, A ^c   van Meijgaarden, K ^c   Geluk, A ^c   Klein, M ^c   Yamuah, L ⁱ   Mihret, A ⁱ   Asseffa, A ⁱ   Aytenew, M ⁱ   Assefa, Y ⁱ   Girma, S ⁱ   Iwnetu, R ⁱ   Tafesse, M ⁱ   Miedema, F ^g   Jacobi, R ^g   Abebe, A ^d   Gebremichael, G ^d   Mesele, T ^d   Tegbaru, B ^d   Alemayehu, Y ^d   Andersen, P ⁿ   Doherty, M ⁿ   Rosenkrands, I ⁿ   Weldingh, K ⁿ   Scriba, T ^l   Hughes, J ^l   Mohamed, H ^l   Abel, B ^l   Bowmaker, M ^l   Kagina, B ^l   Kwong Chung, W ^l   Mulenga, H ^l   Keyser, A ^l   Erasmus, M ^l   Hussey, G ^l   Sadoff, J ^o   Sizemore, D ^o   Barker, L ^o   Brennan, M ^o   Weichold, F ^o   Malone, A ^o   Zhou, J ^o   Mueller, S ^o   Geiter, L ^o   Schoolnik, G ^p   Dolganov, G ^p   Van, T ^p   Golinski, R ^h   Parida, S ^h   Jacobsen, M ^h   Weiner, J ^h   Lauhkonen, R ^h   more..

^a Medical Research Council Unit   (Gambia)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^e KARONGA PREVENTION STUDY   (Malawi)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

ⁱ ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^j MAKERERE UNIVERSITY   (Uganda)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l UNIVERSITY OF CAPE TOWN   (South Africa)

^m MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

ⁿ STATENS SERUM INSTITUT   (Denmark)

^o AERAS   (United States)

^p STANFORD UNIVERSITY   (United States)

more..

Author keywords

Biosignature; Gene expression; RT MLPA; Tuberculosis

Indexed keywords

CD64 ANTIGEN; FC RECEPTOR; RNA; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; ETHIOPIA; ETHNIC DIFFERENCE; EX VIVO STUDY; GAMBIA; GENE; GENE EXPRESSION; GENE NUMBER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS;

BIOSIGNATURE; GENE EXPRESSION; RT-MLPA; TUBERCULOSIS;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; BIOLOGICAL MARKERS; BLOOD; ETHNIC GROUPS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, IGG; TUBERCULOSIS; YOUNG ADULT;

EID: 84895926841     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12383     Document Type: Article

References (28)

1. WHO Global Tuberculosis Report 2012. WHO fact sheet number 104. Available at: http://www.who.int/tb/publications/factsheet_global.pdf (last accessed 29 March 2013).
2. Nunn P, Williams B, Floyd K et al. Tuberculosis control in the era of HIV. Nat Rev Immunol 2005; 5: 819-826.
3. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007; 7: 328-337.
4. Ottenhoff TH, Ellner JJ, Kaufmann SH. Ten challenges for TB biomarkers. Tuberculosis (Edinb) 2012; 92: S17-S20.
5. Kaufmann SH, Parida SK. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 2008; 4: 219-228.
6. Balboa L, Romero MM, Laborde E et al. Impaired dendritic cell differentiation of CD16-positive monocytes in tuberculosis: role of p38 MAPK. Eur J Immunol 2013; 43: 335-347.
7. Martineau AR, Newton SM, Wilkinson KA et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007; 117: 1988-1994.
8. Rodrigues DS, Medeiros EA, Weckx LY et al. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol 2002; 128: 149-154.
9. Goletti D, Butera O, Bizzoni F et al. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006; 194: 984-992.
10. Lewinsohn DA, Heinzel AS, Gardner JM et al. Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med 2003; 168: 1346-1352.
11. Caccamo N, Guggino G, Meraviglia S et al. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS ONE 2009; 4: e5528.
12. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009; 39: 723-729.
13. Caccamo N, Guggino G, Joosten SA et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010; 40: 2211-2220.
14. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009; 9: 21-29.
15. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 2010; 5: e12365.
16. Berry MP, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466: 973-977.
17. Ottenhoff TH, Dass RH, Yang N et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 2012; 7: e45839.
18. Maertzdorf J, Repsilber D, Parida SK et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011; 12: 15-22.
19. Jacobsen M, Repsilber D, Gutschmidt A et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 2007; 85: 613-621.
20. Maertzdorf J, Ota M, Repsilber D et al. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS ONE 2011; 6: e26938.
21. Joosten SA, Goeman JJ, Sutherland JS et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 2012; 13: 71-82.
22. Eldering E, Spek CA, Aberson HL et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 2003; 31: e153.
23. White SJ, Vink GR, Kriek M et al. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat 2004; 24: 86-92.
24. Ratledge C. Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb) 2004; 84: 110-130.
25. Hwang SA, Welsh KJ, Kruzel ML, Actor JK. Lactoferrin augmentation of the BCG vaccine leads to increased pulmonary integrity. Tuberc Res Treat 2011; doi: 10.1155/2011/835410.
26. de Jong BC, Hill PC, Aiken A et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 2008; 198: 1037-1043.
27. Cliff JM, Lee JS, Constantinou N et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013; 207: 18-29.
28. Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1971; 134: 713-740.